Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists

Pharmacology, Biochemistry, and Behavior
Małgorzata ZygmuntJacek Sapa

Abstract

The purpose of the study was to examine derivatives of annelated xanthines (imidazo-, pyrimido-, and diazepino-purinediones) for potential anti-inflammatory effects in carrageenan-induced paw edema in mice. Additionally, their antioxidant activity using the FRAP (ferric-reducing ability of plasma) assay and lipid peroxidation in rat brain homogenate were analyzed. All the studied derivatives showed affinity for adenosine A2A receptor. The preliminary assays found that five (KD-114, KD-57, KD-129, KD-50, and KD-358) pyrimidopurinedione derivatives, administered intraperitoneally (i.p.) at a dose of 100mg/kg, had stronger anti-inflammatory effects. At a concentration of 10-5M, three of the derivatives KD-57, KD-114, and KD-129 most influenced the total antioxidant ability. The most efficient anti-inflammatory compound, KD-114, also showed the strongest binding to A2A receptors and when administered at a dose of 5mg/kg (i.p.), effectively reversed haloperidol-induced catalepsy and significantly increased the striatal extracellular dopamine level in the rat striatum. This effect was weaker than the one produced by CSC (1mg/kg i.p.), and only slightly weaker than that produced by ZM 241385 (3mg/kg i.p.) used as reference drugs. From...Continue Reading

References

Oct 18, 2000·Current Medicinal Chemistry·C E Muller
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Roberto CoccurelloMarianne Amalric
May 4, 2005·The Journal of Thoracic and Cardiovascular Surgery·T Brett ReeceIrving L Kron
Jul 15, 2006·The Journal of Clinical Investigation·Chun-Xiao SunMichael R Blackburn
Jul 18, 2006·Bioorganic & Medicinal Chemistry·Anna DrabczyńskaKatarzyna Kieć-Kononowicz
Nov 29, 2007·Pharmacotherapy·Jack J Chen, David M Swope
Jan 1, 2008·Journal of Ethnopharmacology·Filomena ConfortiRoberto Della Loggia
Jan 12, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Andras Bilkei-GorzoAndreas Zimmer
Jan 29, 2008·Recent Patents on CNS Drug Discovery·Christa E Müller, Sergi Ferré
Feb 3, 2009·Bioorganic & Medicinal Chemistry Letters·Yuefei ShaoIan Henderson
Jun 30, 2009·Respiratory Research·Ashish K SharmaVictor E Laubach
Apr 8, 2010·Current Topics in Medicinal Chemistry·M L TrincavelliC Martini
Apr 20, 2010·The Journal of Thoracic and Cardiovascular Surgery·Leo M GazoniVictor E Laubach
Jun 15, 2011·European Journal of Medicinal Chemistry·Anna DrabczyńskaKatarzyna Kieć-Kononowicz
Aug 4, 2012·ACS Chemical Neuroscience·Brian C Shook, Paul F Jackson
Feb 13, 2013·The Journal of Thoracic and Cardiovascular Surgery·Lucas G FernandezVictor E Laubach
May 24, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Franziska M KonradJörg Reutershan
May 24, 2013·Drugs·Rosselle Dungo, Emma D Deeks
Jul 3, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Mayumi SakiTomoyuki Kanda
Jul 31, 2013·Bioorganic Chemistry·Mietha M Van der WaltJacobus P Petzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.